LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF 10A | JNK-9L | 0.6014 |
| SK-BR-3 | JNK-9L | 0.6699 |
| MDA-MB-231 | JW-7-24-1 | 0.3625 |
| MCF7 | JW-7-24-1 | 0.6808 |
| BT-20 | JW-7-24-1 | 0.2993 |
| Hs 578T | JW-7-24-1 | 0.4056 |
| SK-BR-3 | JW-7-24-1 | 0.5594 |
| MCF 10A | JW-7-24-1 | 0.1490 |
| MDA-MB-231 | KIN001-043 | 0.2179 |
| MCF7 | KIN001-043 | 0.2100 |
| BT-20 | KIN001-043 | 0.0871 |
| Hs 578T | KIN001-043 | 0.0667 |
| SK-BR-3 | KIN001-043 | 0.2662 |
| MCF 10A | KIN001-043 | 0.1013 |
| BT-20 | Lapatinib | 0.0664 |
| MCF7 | Lapatinib | 0.1382 |
| Hs 578T | Lapatinib | 0.0496 |
| SK-BR-3 | Lapatinib | 0.9977 |
| MCF 10A | Lapatinib | 0.1647 |
| MDA-MB-231 | Lapatinib | 0.0923 |
| BT-20 | LDN-193189 | 0.4508 |
| MDA-MB-231 | LDN-193189 | 0.4025 |
| SK-BR-3 | LDN-193189 | 0.3261 |
| Hs 578T | LDN-193189 | 0.3463 |
| MCF7 | LDN-193189 | 0.2909 |